What's Happening?
TOMI Environmental Solutions, Inc., a leader in disinfection and decontamination solutions, has announced a significant expansion in the Cell and Gene Therapy (CGT) sector. The company has implemented its SteraMist ionized Hydrogen Peroxide (iHP) technology at a new pharmaceutical manufacturing site. This multi-stage implementation aims to enhance the facility's Contamination Control Strategy (CCS) to meet current Good Manufacturing Practices (cGMP) requirements. The collaboration includes comprehensive standard operating procedures and qualification packages to ensure a seamless transition to commercial production.
Why It's Important?
The expansion of TOMI Environmental Solutions into the CGT sector underscores the growing demand for advanced sterilization solutions
in biopharmaceutical manufacturing. As the CGT market evolves, the need for scalable and validated contamination control solutions becomes critical. TOMI's technology offers a turnkey approach that aligns with industry standards, supporting the sector's growth and innovation. This development highlights the importance of maintaining high safety and quality standards in pharmaceutical production, which is vital for public health and industry credibility.
